Walgreens Earnings Preview: Revenue Estimates Holding Up Amid EPS Pressure

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 53%

المملكة العربية السعودية أخبار أخبار

المملكة العربية السعودية أحدث الأخبار,المملكة العربية السعودية عناوين

Stocks Analysis by Brian Gilmartin covering: Dell Technologies Inc, Walgreens Boots Alliance Inc. Read Brian Gilmartin's latest article on Investing.com

) is set to report its fiscal Q2 ’24 financial results before the opening bell tomorrow morning, Thursday, March 28th, 2024. Analyst consensus is expecting $38.9 billion in revenue, $672 million in operating income, and $0.82 in EPS, resulting in +3%, – 45%, and -29% yoy growth for the three metrics.

The US Healthcare segment, which was Roz Brewer’s baby was expected to show significant year-on-year profit improvement in fiscal ’24, per the conference call notes. The most troubling valuation metric WBA’s “price-to-revenue” or price-to-sales metric at 0.12x. That’s lower than when Sears Holdings was taken out, or when Michael Dell took Dell (NYSE:

One-time asset liquidations and asset divestitures at WBA are a plus for now, but the business needs to stabilize margins and eventually improve operating income on a reliable basis. A few clients are long the stock between $21 – $23, but it’s not a big position. To own more stock, I would need to see the EPS estimates stabilize and even better, move higher. That would tell me earnings are more in line with revenue.

 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 450. in SA

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين